Details for New Drug Application (NDA): 020441
✉ Email this page to a colleague
The generic ingredient in PULMICORT is budesonide. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 020441
Tradename: | PULMICORT |
Applicant: | Astrazeneca |
Ingredient: | budesonide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020441
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER, METERED;INHALATION | Strength | 0.16MG/INH | ||||
Approval Date: | Jun 24, 1997 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER, METERED;INHALATION | Strength | 0.32MG/INH | ||||
Approval Date: | Jun 24, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020441
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | PULMICORT | budesonide | POWDER, METERED;INHALATION | 020441-002 | Jun 24, 1997 | 4,524,769 | ⤷ Subscribe |
Astrazeneca | PULMICORT | budesonide | POWDER, METERED;INHALATION | 020441-003 | Jun 24, 1997 | 4,907,583*PED | ⤷ Subscribe |
Astrazeneca | PULMICORT | budesonide | POWDER, METERED;INHALATION | 020441-003 | Jun 24, 1997 | 4,524,769 | ⤷ Subscribe |
Astrazeneca | PULMICORT | budesonide | POWDER, METERED;INHALATION | 020441-003 | Jun 24, 1997 | 4,668,218*PED | ⤷ Subscribe |
Astrazeneca | PULMICORT | budesonide | POWDER, METERED;INHALATION | 020441-002 | Jun 24, 1997 | 4,907,583*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription